A Monoclonal Antibody for Migraine Prevention | NEJM
Some patients with migraine cannot take existing preventive medications. An investigational humanized monoclonal antibody, Lu AG09222, targets a potential mediator of migraine.
Research findings are summarized in a new Quick Take video.
To see the full article, follow this link: https://nej.md/4dQymPH
#neurology #neurosurgery #endocrinology #clinicalmedicine #nejm
